Sabin Vaccine Institute Receives $150,000 Grant to Strategize for Introduction and Sustainable Use of Vaccines in Developing Countries

WASHINGTON — The Albert B. Sabin Vaccine Institute (SVI), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005. The SVI will use this grant to convene a meeting of international public health, government, and industry experts on the “Introduction and Sustainable Use of Vaccines in Developing Countries.”

For each of the past 11 years the Institute has organized a high-level meeting where experts consider a vaccine policy issue of global importance. Subjects will include developing country challenges for long-term immunization programs, vaccine financing, vaccine supply, political commitment, and how best to coordinate the working relationships and responsibilities among the myriad of programs that provide assistance.

View The Albert B. Sabin Vaccine Institute Website.